Cargando…

Systemic treatment of advanced/metastatic renal cell carcinoma in the context of SARS-CoV-2 pandemic: recommendations from the interdisciplinary working group for renal tumors (IAG-N)

This letter summarizes recommendations from the interdisciplinary working group of renal tumors (IAGN) of the German Cancer Society for the systemic treatment of advanced/metastatic renal cell carcinoma in the context of the current SARS-CoV-2 pandemic

Detalles Bibliográficos
Autores principales:	Ivanyi, Philipp, Grüllich, Carsten, Kroeger, Nils, Gauler, Thomas, Johannsen, Manfred, Bedke, Jens, Grünwald, Viktor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438397/ https://www.ncbi.nlm.nih.gov/pubmed/32816108 http://dx.doi.org/10.1007/s00432-020-03341-4

Ejemplares similares

Systemic therapy in metastatic renal cell carcinoma (mRCC): an evidence-based recommendation of the German interdisciplinary RCC guidelines group
por: Grünwald, V., et al.
Publicado: (2022)

Systemic therapy in metastatic renal cell carcinoma
por: Bedke, Jens, et al.
Publicado: (2016)

Predictive Factors for Second-Line Therapy in Metastatic Renal Cell Carcinoma: A Retrospective Analysis
por: Eggers, Hendrik, et al.
Publicado: (2017)

First Line Medical Treatment of Metastatic Renal Cell Carcinoma: A Podcast on Choosing Wisely and Managing Safely
por: Ivanyi, Philipp, et al.
Publicado: (2023)

An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma
por: Grünwald, Viktor, et al.
Publicado: (2018)

A Podcast Discussion on the Current Treatment Landscape for Renal Cell Carcinoma
por: Ivanyi, Philipp, et al.
Publicado: (2023)

IAG Newsletter
por: Tóth, Gyula
Publicado: (2021)

IAG Newsletter
por: Tóth, Gyula
Publicado: (2021)

IAG Newsletter
por: Tóth, Gyula
Publicado: (2021)

CT patterns of organizing pneumonia in patients treated with VEGF/mTOR inhibitors for metastatic renal cell cancer: an observational study
por: Dettmer, Sabine, et al.
Publicado: (2017)

President’s Message for IAGE Journal
por: Sinha, Rakesh
Publicado: (2009)

President's Message for IAGE Journal
por: Sinha, Rakesh
Publicado: (2011)

Improving survival in metastatic renal cell carcinoma (mRCC) patients: do elderly patients benefit from expanded targeted therapeutic options?
por: Eggers, Hendrik, et al.
Publicado: (2022)

Tumour response in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors – assessment of intra-tumour heterogeneity
por: Stühler, Viktoria, et al.
Publicado: (2016)

Retrospective comparison of the different immune combinations in metastatic renal cell carcinoma
por: Grünwald, Viktor, et al.
Publicado: (2020)

Real world data on IO-based therapy for metastatic renal cell carcinoma
por: Stühler, Viktoria, et al.
Publicado: (2022)

29th International Applied Geochemistry Symposium (IAGS)
Publicado: (2022)

Two Short Repeats in the 5′ Untranslated Region of Insulin-like Androgenic Gland Factor in Procambarus clarkii (PcIAG) That Regulate PcIAG Expression
por: Yang, Siqi, et al.
Publicado: (2022)

Axitinib for the treatment of patients with advanced metastatic renal cell carcinoma (mRCC) after failure of prior systemic treatment
por: Grünwald, Viktor, et al.
Publicado: (2012)

Brookhaven : Vers de nouvelles performances à I'AGS
Publicado: (1977)

Role of the Systemic Immune-Inflammation Index in Patients with Metastatic Renal Cell Carcinoma Treated with First-Line Ipilimumab plus Nivolumab
por: Stühler, Viktoria, et al.
Publicado: (2022)

Prospective single center trial of next-generation sequencing analysis in metastatic renal cell cancer: the MORE-TRIAL
por: Dieffenbacher, Svenja, et al.
Publicado: (2018)

Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapies
por: Stühler, Viktoria, et al.
Publicado: (2022)

Intrinsic resistance to tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinoma
por: Busch, Jonas, et al.
Publicado: (2011)

Brookhaven : Pour ses 20 ans, I'AGS se distingue
Publicado: (1980)

IAG Regulates the Expression of Cytoskeletal Protein-Encoding Genes in Shrimp Testis
por: Lv, Qian, et al.
Publicado: (2023)

Identification of a Putative CFSH Receptor Inhibiting IAG Expression in Crabs
por: Liu, Fang, et al.
Publicado: (2023)

Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
por: Büttner, Florian, et al.
Publicado: (2018)

The “IAG-Switch”—A Key Controlling Element in Decapod Crustacean Sex Differentiation
por: Levy, Tom, et al.
Publicado: (2020)

Circulating endothelial cells are an early predictor in renal cell carcinoma for tumor response to sunitinib
por: Gruenwald, Viktor, et al.
Publicado: (2010)

Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC
por: Ribback, Silvia, et al.
Publicado: (2021)

UCP-3 uncoupling protein confers hypoxia resistance to renal epithelial cells and is upregulated in renal cell carcinoma
por: Braun, Norbert, et al.
Publicado: (2015)

A Rare Case of Synchronous Renal Cell Carcinoma of the Bladder Presenting With Gross Hematuria
por: Kruck, Stephan, et al.
Publicado: (2013)

IAGS: Inferring Ancestor Genome Structure under a Wide Range of Evolutionary Scenarios
por: Gao, Shenghan, et al.
Publicado: (2022)

Cardio-Renal Metabolic Syndrome: Interdisciplinary Diagnostic Methods
por: Bungau, Simona Gabriela
Publicado: (2023)

Re: Maria J. Ribal, Philip Cornford, Alberto Briganti, et al. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.056: Metastatic Prostate Cancer and COVID-19: Do Current Data Allow Modification of Established Treatment Recommendations?
por: Thomas, Christian, et al.
Publicado: (2020)

Impact of sarcopenia in advanced and metastatic soft tissue sarcoma
por: Strassmann, Dennis, et al.
Publicado: (2021)

Cabozantinib: an Active Novel Multikinase Inhibitor in Renal Cell Carcinoma
por: Tannir, Nizar M., et al.
Publicado: (2017)

Transcriptional Inhibition of Sp-IAG by Crustacean Female Sex Hormone in the Mud Crab, Scylla paramamosain
por: Jiang, Qingling, et al.
Publicado: (2020)

Sex-Biased CHHs and Their Putative Receptor Regulate the Expression of IAG Gene in the Shrimp Litopenaeus vannamei
por: Guo, Qing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_609tns1pml8qqtg6n892nt24en